Double-Blind Study of Miglitol in Japanese With type2 Diabetes
Information source: Sanwa Kagaku Kenkyusho Co., Ltd.
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Type 2 Diabetes Mellitus
Intervention: miglitol (Drug)
Phase: Phase 3
Sponsored by: Sanwa Kagaku Kenkyusho Co., Ltd.
Official(s) and/or principal investigator(s):
Clinical study Group, Clinical Development Dept., Study Director, Affiliation: Sanwa Kagaku Kenkyusho Co., Ltd.
To investigate the efficacy and safety of miglitol in Japanese patients with type 2 diabetes
that is insufficiently controlled diet alone.
Study design: Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Minimum age: 20 Years.
Maximum age: 69 Years.
- Type2 diabetic patient on Dietary Therapy
- Criteria for postprandial plasma glucose and HbA1c are met
- Type1 diabetes
- Patients treated with antidiabetic drugs or Insulin
Locations and Contacts
Last updated: September 25, 2006